IMS Calls Special Policy Forum

Date of Publication November 10, 2017

In accordance with Article VIII, Section 4 of the IMS Bylaws, IMS President Joyce Vista-Wayne, MD, DFAPA, has requested a special meeting of the Policy Forum to be held on Thursday, December 14, immediately following the conclusion of the IMS Board of Directors meeting. With the concurrence of the Board of Directors, notification is provided to the membership in accordance with the bylaws.

Article VIII, Section 4: Special meetings of the Policy Forum shall be called by the President, with concurrence by the Board of Directors, or upon written petition of twenty (20) members, not more than four (4) of whom are from any one (1) component society. Rules governing the conduct of such special meetings shall be those that generally apply to meetings of the Policy Forum.

Agenda

  1. PRS 17-3-01: Policy Forum Speaker: Amend the IMS bylaws to allow the Board of Directors to appoint an individual who has been vetted by the Nominating Committee to serve as Policy Forum Speaker.
  2. PRS 17-3-02: President-Elect At-Large Vacancy: Amend the IMS bylaws to specify that only individuals who have been vetted by the Nominating Committee are eligible for appointment to serve out the duration of the At-Large term vacated when the President-Elect begins his or her term of office.
  3. PRS 17-3-03: IMS Membership for Administrative License Physicians: Amend the IMS bylaws to allow physicians who have an active administrative medical license to become an active IMS member.
  4. PRS 17-3-04: IMS Administrative Membership Category: Amend the IMS bylaws to create a new IMS membership category for physicians who are eligible to receive an administrative medical license, but have not done so.
Members are invited to submit their thoughts on these proposed amendments via the IMS Testimony Forum. The Testimony Forum closes on Saturday, November 25. For more information, please contact Dennis Tibben with the IMS Center for Physician Advocacy.

Recent News

Please Join Us Thursday, October 18 for the Next Installment in the IMS Physician Burnout Series

IMS is committed to combatting physician burnout and professional resiliency, and creating collaboration opportunities in local settings throughout the year. We invite you to collaborate with physicians, clinic administrators, insurance regulators, a

IMS Weighs in on Medicare Fee Schedule Rule

IMS submitted written comments on hte proposed revisions to payment policies under Medicare Part B Physician Fee Schedule (PFS).

New Prescription Monitoring and CME Mandates take effect July 1st. Are you Impacted?

The new Opioid Omnibus Legislation, effective July 1, will change requirements for prescribers.

IBM Advances Draft Psychologist Prescribing Rules

The Iowa Board of Medicine (IBM), at its June 8 meeting, voted to move forward with draft administrative rules to allow psychologists who have received additional pharmacology training to begin issuing prescriptions for psychotropic medications. Thes

Meet IMS At-Large Director Damon Dyche, MD

In April the IMS membership elected new members to the IMS Board of Director. Meet newly elected IMS At-Large Director, Damon Dyche, MD.

Closer Look at Lenard Kerr, DO

In April the IMS membership elected new members to the IMS Board of Director. Meet newly elected IMS At-Large Director, Damon Dyche, MD.

Got News?

Is there something you think we should be covering? What would you like to see IMS report on? Click here to let us know.